Skip to content

Allotment

Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals launched a book-built IPO worth ₹29.75 crore, consisting entirely of a fresh issue of 0.29 crore shares.

The IPO opened for bidding on May 14, 2025, and closed on May 16, 2025. The allotment was finalized on May 19, 2025, and the shares were subsequently listed on NSE SME on May 21, 2025.

The price band for the IPO was fixed at ₹101 per share. The lot size for an application is 1,200 shares. For retail investors, the minimum investment is 1 lot (1,200 shares), amounting to ₹1,21,200 (based on the upper price). HNI investors must subscribe to a minimum of 2 lots (2,400 shares), totaling ₹2,42,400.

The IPO was managed by Jawa Capital Services Pvt. Ltd. as the Book Running Lead Manager, with Kfin Technologies Ltd. serving as the Registrar of the Issue. Gretex Share Broking Pvt. Ltd. acted as the market maker for the IPO.

Investors can bid for a minimum of 1,200 shares, with additional bids required in multiples of 1,200 shares.

Accretion Pharmaceuticals Limited IPO & Charts
₹101

0%

Open

₹101

HIgh - Low

₹101

Previous Close

₹101

Total Traded Value

0

52 Weeks High

₹101

52 Weeks Low

₹101

Updates On

May 5, 2025

IPO. Open

May 14, 2026

IPO. Close

May 16, 2026

IPO. Price

₹101.00

IPO Market price

₹112.27 Cr

IPO Details

IPO Date 21 May
IPO Listing Date 21 May
IPO Face Value ₹10 per share
IPO Price Range ₹101.00
IPO Issue Size 29,46,000 shares
IPO Sale Type Fresh Capital
Employee Discount -
IPO Issue Type Bookbuilding IPO
IPO Listing NSE SME Platform
hare Holding Pre Issue 81,70,000 shares

IPO Timeline

IPO Open Date 14 May
IPO Close Date 16 May
IPO Allotment (Tentative) 19 May
Refunds 20 May
Credit to Demat Account 20 May
IPO Listing Date 21 May

IPO Reservation

Category Offer
QIB Shares Offered 3,52,800 Shares
NII (HNI) Shares Offered 12,22,800 Shares
Retail Shares Offered 12,22,800 Shares

IPO Lot Size

Investors can bid for a minimum of 1,200 shares, with additional bids required in multiples of 1,200 shares.

Application Lots Share Amount
Retail (Min) 1 1,200 ₹1,21,200
Retail (Max) 1 1,200 ₹1,21,200
S-HNI (Min) 2 2,400 ₹2,42,400
S-HNI (Max) - - -
B-HNI (Min) - - -
About Company

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical manufacturing company engaged in the production and sale of tablets, capsules, and a wide range of healthcare products. The company also provides contract manufacturing services, catering to domestic and international markets.

Manufacturing and Certifications:
The company’s manufacturing facility is located in Ahmedabad (Sanand), Gujarat, and is supported by internationally recognized quality standards. Accretion Pharmaceuticals holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, demonstrating its commitment to quality assurance, food safety, and environmental management systems.

Product Portfolio and Services:
Accretion Pharmaceuticals manufactures and markets a diverse range of formulations, including:

Tablets and Capsules – Covering antibiotics, anti-inflammatory drugs, pain management, cardiovascular, and gastrointestinal medicines.

Oral Liquids and Syrups – Used in respiratory, pediatric, and digestive treatments.

External Preparations – Including ointments, creams, gels, lotions, medicated shampoos, mouthwashes, and dusting powders for dermatological care.

Oral Powders – Such as sachets and dry syrups.

Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and overall health.

Global Presence:
The company has expanded its international footprint, with operations in more than 20 countries, including regions across Africa, Southeast Asia, and the Middle East.

Workforce:
As of January 2025, Accretion Pharmaceuticals employed 83 personnel, including 4 Executive Directors.

Competitive Strengths:

Experienced promoters and a capable management team

Long-standing relationships with clients and suppliers

Strong focus on delivering high-quality pharmaceutical products

Well-established supply chain and customer relationships, fostering trust and goodwill

-

Company Financials (Consolidated)

Assets 39.99 27.05 20.58
Total Income 35.75 33.94 29.53
Profit After Tax 5.24 3.88 0.1
EBITDA - - -
NET Worth 13.58 5.35 3.84
Reserves and Surplus 5.41 1.35 -
Total Borrowing 13.79 13.48 8.47

Key Performance Indicator (KPI)

ROE 72.47%
ROCE 36.73%
Debt/Equity 2.52
RoNW 72.47%
PAT Margin 11.51%
EBITDA Margin -
Price to Book Value 7.55
IPO Objective

IPO Objects of the Issue

S.No. Objects of the ipo Resources Detail IPO Amount
1 Funding capital expenditure requirements for the purchase of equipment/machineries 2.7
2 To meet out the expenses of Working Capital Requirement 14.68
3 To meet out the General Corporate Purposes; 4.43
4 Offer for Sale (OFS) -

Contact Details

Accretion Pharmaceuticals Ltd. Address
29 Xcelon Ind Park 1,
B/h, Intas Pharmaceuticals, Vasna Chacharvad
Sanand,
Ahmedabad, Gujarat, 382213
+91-97148 82929
compliance@accretionpharma.com

Home

Detail Registrar

IPO Registrar

Kfin Technologies Ltd.
04067162222, 04079611000
apl.ipo@kfintech.com
https://ipostatus.kfintech.com/

Compare:

Back To Top